Chemoinformaics analysis of 1D-4-O-methyl-myo-inositol
| Molecular Weight | 194.183 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.071 | nRig | 6 |
| Exact Molecular Weight | 194.079 | nRing | 1 |
| Solubility: LogS | -0.195 | nHRing | 0 |
| Solubility: LogP | -2.423 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 25.8371 |
| nHD | 5 | BPOL | 15.7809 |
| QED | 0.301 |
| Synth | 3.442 |
| Natural Product Likeliness | 1.562 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.473 |
| HIA | 0.946 |
| CACO-2 | -5.252 |
| MDCK | 0.000823471 |
| BBB | 0.741 |
| PPB | 0.126877 |
| VDSS | 0.9 |
| FU | 0.724448 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.07 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.117 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.01 |
| CL | 1.301 |
| T12 | 0.498 |
| hERG | 0.076 |
| Ames | 0.068 |
| ROA | 0.036 |
| SkinSen | 0.034 |
| Carcinogencity | 0.01 |
| EI | 0.025 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.891654 |